48 results on '"Vinkemeier U"'
Search Results
2. Ethische Folgeneinschätzung von Genotyp-basierten Arzneimitteltherapien
- Author
-
Meyer, T, primary, Vinkemeier, U, additional, and Meyer, U, additional
- Published
- 2002
- Full Text
- View/download PDF
3. TYROSINE PHOSPHORYLATED STAT-1/DNA COMPLEX
- Author
-
Kuriyan, J., primary, Zhao, Y., additional, Chen, X., additional, Vinkemeier, U., additional, Jeruzalmi, D., additional, and Darnell Jr., J.E., additional
- Published
- 1998
- Full Text
- View/download PDF
4. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites.
- Author
-
Vinkemeier, U., primary, Cohen, S. L., additional, Moarefi, I., additional, Chait, B. T., additional, Kuriyan, J., additional, and Darnell, J. E., additional
- Published
- 1996
- Full Text
- View/download PDF
5. The globular head domain of titin extends into the center of the sarcomeric M band. cDNA cloning, epitope mapping and immunoelectron microscopy of two titin-associated proteins
- Author
-
Vinkemeier, U., primary, Obermann, W., additional, Weber, K., additional, and Furst, D.O., additional
- Published
- 1993
- Full Text
- View/download PDF
6. Mammalian skeletal muscle C-protein: purification from bovine muscle, binding to titin and the characterization of a full-length human cDNA
- Author
-
Furst, D.O., primary, Vinkemeier, U., additional, and Weber, K., additional
- Published
- 1992
- Full Text
- View/download PDF
7. Purification and physical properties of nematode mini-titins and their relation to twitchin
- Author
-
Nave, R., primary, Furst, D., additional, Vinkemeier, U., additional, and Weber, K., additional
- Published
- 1991
- Full Text
- View/download PDF
8. A family-wide assessment of latent STAT transcription factor interactions reveals divergent dimer repertoires.
- Author
-
Begitt A, Krause S, Cavey JR, Vinkemeier DE, and Vinkemeier U
- Subjects
- Cytokines metabolism, Phosphorylation, STAT1 Transcription Factor genetics, STAT1 Transcription Factor metabolism, STAT2 Transcription Factor genetics, STAT2 Transcription Factor metabolism, STAT3 Transcription Factor genetics, STAT3 Transcription Factor metabolism, STAT4 Transcription Factor genetics, STAT4 Transcription Factor metabolism, STAT5 Transcription Factor genetics, STAT5 Transcription Factor metabolism, Protein Multimerization, Gene Expression Regulation, Trans-Activators metabolism, STAT Transcription Factors genetics, STAT Transcription Factors metabolism
- Abstract
The conversion of signal transducer and activator of transcription (STAT) proteins from latent to active transcription factors is central to cytokine signaling. Triggered by their signal-induced tyrosine phosphorylation, it is the assembly of a range of cytokine-specific STAT homo- and heterodimers that marks a key step in the transition of hitherto latent proteins to transcription activators. In contrast, the constitutive self-assembly of latent STATs and how it relates to the functioning of activated STATs is understood less well. To provide a more complete picture, we developed a co-localization-based assay and tested all 28 possible combinations of the seven unphosphorylated STAT (U-STAT) proteins in living cells. We identified five U-STAT homodimers-STAT1, STAT3, STAT4, STAT5A, and STAT5B-and two heterodimers-STAT1:STAT2 and STAT5A:STAT5B-and performed semi-quantitative assessments of the forces and characterizations of binding interfaces that support them. One STAT protein-STAT6-was found to be monomeric. This comprehensive analysis of latent STAT self-assembly lays bare considerable structural and functional diversity in the ways that link STAT dimerization before and after activation., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
9. Lack of STAT1 co-operative DNA binding protects against adverse cardiac remodelling in acute myocardial infarction.
- Author
-
Doudin A, Riebeling T, Staab J, Menon PR, Lühder F, Wirths O, Vinkemeier U, Ivetic A, and Meyer T
- Abstract
In this study, we addressed the functional significance of co-operative DNA binding of the cytokine-driven transcription factor STAT1 (signal transducer and activator of transcription 1) in an experimental murine model of acute myocardial infarction (MI). STAT1 knock-in mice expressing a phenylalanine-to-alanine substitution at position 77 in the STAT1 amino-terminal domain were examined for the early clinical effects produced by ligation of the left anterior descending coronary artery (LAD), an established model for MI. The F77A mutation has been previously reported to disrupt amino-terminal interactions between adjacent STAT1 dimers resulting in impaired tetramerization and defective co-operative binding on DNA, while leaving other protein functions unaffected. Our results demonstrate that a loss of STAT1 tetramer stabilization improves survival of adult male mice and ameliorates left ventricular dysfunction in female mice, as determined echocardiographically by an increased ejection fraction and a reduced left intra-ventricular diameter. We found that the ratio of STAT3 to STAT1 protein level was higher in the infarcted tissue in knock-in mice as compared to wild-type (WT) mice, which was accompanied by an enhanced infiltration of immune cells in the infarcted area, as determined by histology. Additionally, RNA sequencing of the infarcted tissue 24 h after LAD ligation revealed an upregulation of inflammatory genes in the knock-in mice, as compared to their WT littermates. Concomitantly, genes involved in oxidative phosphorylation and other metabolic pathways showed a significantly more pronounced downregulation in the infarcted tissue from STAT1
F77A/F77A mice than in WT animals. Based on these results, we propose that dysfunctional STAT1 signalling owing to a lack of oligomerisation results in a compensatory increase in STAT3 expression and promotes early infiltration of immune cells in the infarcted area, which has beneficial effects on left ventricular remodelling in early MI following LAD ligation., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Doudin, Riebeling, Staab, Menon, Lühder, Wirths, Vinkemeier, Ivetic and Meyer.)- Published
- 2023
- Full Text
- View/download PDF
10. Effects of substance P on human cerebral microvascular endothelial cell line hCMEC/D3 are mediated exclusively through a truncated NK-1 receptor and depend on cell confluence.
- Author
-
Gao X, Frakich N, Filippini P, Edwards LJ, Vinkemeier U, Gran B, Tanasescu R, Bayraktutan U, Colombo S, and Constantinescu CS
- Subjects
- Blood-Brain Barrier metabolism, Cell Line, Humans, Occludin metabolism, Occludin pharmacology, Substance P metabolism, Substance P pharmacology, Endothelial Cells, Receptors, Neurokinin-1 metabolism
- Abstract
The neuropeptide substance P (SP) mediates pain transmission, immune modulation, vasodilation and neurogenic inflammation. Its role in the peripheral nervous system has been well characterised. However, its actions on the blood-brain barrier (BBB) are less clear and warrant further study. The aim of this study was to characterise the effect of SP on the brain microvascular endothelial cells using the immortalized human brain microvascular endothelial cell line hCMEC/D3. As part of our studies, we have evaluated changes in expression, at mRNA and protein levels, of genes involved in the function of the blood-brain barrier such as occludin, induced by exposure to SP. We show that the effect of SP is dependent on cell confluence status. Thus, at low confluence but not at full confluence, SP treatment reduced occludin expression. The expression of the SP receptor, neurokinin-1 receptor (NK-1R) (the truncated form of the receptor expressed exclusively in this cell line) was also modulated in a similar pattern. SP treatment stimulated extracellular signal-regulated kinase (Erk2) phosphorylation which was not associated to changes in Interleukin-6 (IL-6), Interleukin-8 (IL-8), or Intercellular Adhesion Molecule 1 (ICAM-1) protein expression. In addition, SP treatment effectively recovered nitric oxide production on cells exposed to tumour necrosis factor alpha (TNF-α). SP did not trigger intracellular calcium release in hCMEC/D3 cells. We conclude that hCMEC/D3 cells are partially responsive to SP, that the effects are mediated through the truncated form of the receptor and are dependent on the confluence status of these cells., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
11. On the role of STAT1 and STAT6 ADP-ribosylation in the regulation of macrophage activation.
- Author
-
Begitt A, Cavey J, Droescher M, and Vinkemeier U
- Subjects
- ADP-Ribosylation, Macrophage Activation
- Published
- 2018
- Full Text
- View/download PDF
12. Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO).
- Author
-
Droescher M, Begitt A, Marg A, Zacharias M, and Vinkemeier U
- Published
- 2017
- Full Text
- View/download PDF
13. STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling Pathways.
- Author
-
Ho J, Pelzel C, Begitt A, Mee M, Elsheikha HM, Scott DJ, and Vinkemeier U
- Subjects
- Animals, Binding Sites, Cell Nucleus metabolism, DNA metabolism, Dimerization, Gene Expression physiology, Humans, Interferon-gamma metabolism, Interferon-gamma physiology, Phosphorylation, Protein Binding, Protein Conformation, STAT1 Transcription Factor metabolism, STAT2 Transcription Factor metabolism, STAT1 Transcription Factor antagonists & inhibitors, STAT2 Transcription Factor physiology, Signal Transduction
- Abstract
STAT2 is the quintessential transcription factor for type 1 interferons (IFNs), where it functions as a heterodimer with STAT1. However, the human and murine STAT2-deficient phenotypes suggest important additional and currently unidentified type 1 IFN-independent activities. Here, we show that STAT2 constitutively bound to STAT1, but not STAT3, via a conserved interface. While this interaction was irrelevant for type 1 interferon signaling and STAT1 activation, it precluded the nuclear translocation specifically of STAT1 in response to IFN-γ, interleukin-6 (IL-6), and IL-27. This is explained by the dimerization between activated STAT1 and unphosphorylated STAT2, whereby the semiphosphorylated dimers adopted a conformation incapable of importin-α binding. This, in turn, substantially attenuated cardinal IFN-γ responses, including MHC expression, senescence, and antiparasitic immunity, and shifted the transcriptional output of IL-27 from STAT1 to STAT3. Our results uncover STAT2 as a pervasive cytokine regulator due to its inhibition of STAT1 in multiple signaling pathways and provide an understanding of the type 1 interferon-independent activities of this protein., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2016
- Full Text
- View/download PDF
14. TLR2 stimulation regulates the balance between regulatory T cell and Th17 function: a novel mechanism of reduced regulatory T cell function in multiple sclerosis.
- Author
-
Nyirenda MH, Morandi E, Vinkemeier U, Constantin-Teodosiu D, Drinkwater S, Mee M, King L, Podda G, Zhang GX, Ghaemmaghami A, Constantinescu CS, Bar-Or A, and Gran B
- Subjects
- Adult, Case-Control Studies, Cell Differentiation drug effects, Cytokines biosynthesis, Female, Humans, Immunomodulation, Immunophenotyping, Lipoproteins pharmacology, Male, Middle Aged, Multiple Sclerosis, Relapsing-Remitting immunology, Multiple Sclerosis, Relapsing-Remitting metabolism, STAT3 Transcription Factor metabolism, T-Lymphocyte Subsets drug effects, T-Lymphocyte Subsets immunology, T-Lymphocyte Subsets metabolism, T-Lymphocytes, Regulatory cytology, Th17 Cells cytology, Toll-Like Receptor 2 agonists, Young Adult, Multiple Sclerosis immunology, Multiple Sclerosis metabolism, T-Lymphocytes, Regulatory immunology, T-Lymphocytes, Regulatory metabolism, Th17 Cells immunology, Th17 Cells metabolism, Toll-Like Receptor 2 metabolism
- Abstract
CD4(+)CD25(hi) FOXP3(+) regulatory T cells (Tregs) maintain tolerance to self-Ags. Their defective function is involved in the pathogenesis of multiple sclerosis (MS), an inflammatory demyelinating disease of the CNS. However, the mechanisms of such defective function are poorly understood. Recently, we reported that stimulation of TLR2, which is preferentially expressed by human Tregs, reduces their suppressive function and skews them into a Th17-like phenotype. In this study, we tested the hypothesis that TLR2 activation is involved in reduced Treg function in MS. We found that Tregs from MS patients expressed higher levels of TLR2 compared with healthy controls, and stimulation with the synthetic lipopeptide Pam3Cys, an agonist of TLR1/2, reduced Treg function and induced Th17 skewing in MS patient samples more than in healthy controls. These data provide a novel mechanism underlying diminished Treg function in MS. Infections that activate TLR2 in vivo (specifically through TLR1/2 heterodimers) could shift the Treg/Th17 balance toward a proinflammatory state in MS, thereby promoting disease activity and progression., (Copyright © 2015 by The American Association of Immunologists, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
15. STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling.
- Author
-
Begitt A, Droescher M, Meyer T, Schmid CD, Baker M, Antunes F, Knobeloch KP, Owen MR, Naumann R, Decker T, and Vinkemeier U
- Subjects
- Animals, Cells, Cultured, DNA metabolism, Interferon-Stimulated Gene Factor 3 metabolism, Listeriosis immunology, Mice, Mice, Inbred C57BL, Mice, Transgenic, Mutant Proteins genetics, Protein Binding genetics, Protein Engineering, STAT1 Transcription Factor genetics, Signal Transduction genetics, Transgenes genetics, Vesicular stomatitis Indiana virus, Interferon Type I metabolism, Interferon-gamma metabolism, Mutant Proteins metabolism, STAT1 Transcription Factor metabolism
- Abstract
STAT1 is an indispensable component of a heterotrimer (ISGF3) and a STAT1 homodimer (GAF) that function as transcription regulators in type 1 and type 2 interferon signaling, respectively. To investigate the importance of STAT1-cooperative DNA binding, we generated gene-targeted mice expressing cooperativity-deficient STAT1 with alanine substituted for Phe77. Neither ISGF3 nor GAF bound DNA cooperatively in the STAT1F77A mouse strain, but type 1 and type 2 interferon responses were affected differently. Type 2 interferon-mediated transcription and antibacterial immunity essentially disappeared owing to defective promoter recruitment of GAF. In contrast, STAT1 recruitment to ISGF3 binding sites and type 1 interferon-dependent responses, including antiviral protection, remained intact. We conclude that STAT1 cooperativity is essential for its biological activity and underlies the cellular responses to type 2, but not type 1 interferon.
- Published
- 2014
- Full Text
- View/download PDF
16. Evidence against a role for β-arrestin1 in STAT1 dephosphorylation and the inhibition of interferon-γ signaling.
- Author
-
Pelzel C, Begitt A, Wenta N, and Vinkemeier U
- Subjects
- Animals, Arrestins deficiency, Arrestins genetics, Genes, Reporter, HEK293 Cells, HeLa Cells, Humans, Mice, Phosphorylation, Protein Binding, Protein Tyrosine Phosphatase, Non-Receptor Type 2 metabolism, Time Factors, Transfection, Tyrosine, beta-Arrestins, Arrestins metabolism, Interferon-gamma metabolism, STAT1 Transcription Factor metabolism, Signal Transduction
- Abstract
Signal transducer and activator of transcription 1 (STAT1) is activated by tyrosine phosphorylation upon interferon-γ (IFNγ) stimulation, which results in the expression of genes with antiproliferative and immunomodulatory functions. The inactivation of STAT1 occurs through tyrosine dephosphorylation by the tyrosine phosphatase TC45. It was proposed that recruitment of TC45 required the direct interaction of STAT1 with the scaffold protein β-arrestin1, making β-arrestin1 an essential negative regulator of STAT1 and IFNγ signaling (Mo et al., 2008). We tested the relevance of β-arrestin1 for STAT1 activity. Our results do not confirm β-arrestin1 as a STAT1-interacting protein. The STAT1 phosphorylation/dephosphorylation cycle was found to be unaffected by both the overexpression and the genetic deletion of β-arrestin1. Accordingly, β-arrestin1 did not inhibit STAT1 transcriptional activity or the induction of IFNγ target genes in response to IFNγ. Our data indicate that β-arrestin1 is dispensable for STAT1 dephosphorylation and the termination of IFNγ signaling., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
17. Characterization of STAT self-association by analytical ultracentrifugation.
- Author
-
Wenta N and Vinkemeier U
- Subjects
- Hydrodynamics, Protein Structure, Quaternary, Solutions, Thermodynamics, Protein Multimerization, STAT Transcription Factors chemistry, Ultracentrifugation methods
- Abstract
Multiple experimental tools have demonstrated that cytokine-induced STAT activation entails the transition of dimer conformations rather than de novo dimerization. In this chapter, we describe the utilization of analytical ultracentrifugation (AUC) as a powerful technique for the quantitative analysis of hydro- and thermodynamic properties of STAT proteins in solution. These studies provided a quantitative understanding of dimer stability and conformational transitions associated with the activation of STAT1.
- Published
- 2013
- Full Text
- View/download PDF
18. STAT1:DNA sequence-dependent binding modulation by phosphorylation, protein:protein interactions and small-molecule inhibition.
- Author
-
Bonham AJ, Wenta N, Osslund LM, Prussin AJ 2nd, Vinkemeier U, and Reich NO
- Subjects
- Base Sequence, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors metabolism, DNA chemistry, Phosphorylation, Protein Multimerization, Proto-Oncogene Proteins c-myc metabolism, Repressor Proteins metabolism, STAT1 Transcription Factor antagonists & inhibitors, STAT1 Transcription Factor chemistry, DNA metabolism, STAT1 Transcription Factor metabolism
- Abstract
The DNA-binding specificity and affinity of the dimeric human transcription factor (TF) STAT1, were assessed by total internal reflectance fluorescence protein-binding microarrays (TIRF-PBM) to evaluate the effects of protein phosphorylation, higher-order polymerization and small-molecule inhibition. Active, phosphorylated STAT1 showed binding preferences consistent with prior characterization, whereas unphosphorylated STAT1 showed a weak-binding preference for one-half of the GAS consensus site, consistent with recent models of STAT1 structure and function in response to phosphorylation. This altered-binding preference was further tested by use of the inhibitor LLL3, which we show to disrupt STAT1 binding in a sequence-dependent fashion. To determine if this sequence-dependence is specific to STAT1 and not a general feature of human TF biology, the TF Myc/Max was analysed and tested with the inhibitor Mycro3. Myc/Max inhibition by Mycro3 is sequence independent, suggesting that the sequence-dependent inhibition of STAT1 may be specific to this system and a useful target for future inhibitor design.
- Published
- 2013
- Full Text
- View/download PDF
19. Activated STAT1 transcription factors conduct distinct saltatory movements in the cell nucleus.
- Author
-
Speil J, Baumgart E, Siebrasse JP, Veith R, Vinkemeier U, and Kubitscheck U
- Subjects
- Cell Survival, Cell Tracking, Cytosol metabolism, Fluorescent Dyes metabolism, HeLa Cells, Humans, Mutant Proteins metabolism, Protein Transport, STAT1 Transcription Factor chemistry, Cell Nucleus metabolism, STAT1 Transcription Factor metabolism
- Abstract
The activation of STAT transcription factors is a critical determinant of their subcellular distribution and their ability to regulate gene expression. Yet, it is not known how activation affects the behavior of individual STAT molecules in the cytoplasm and nucleus. To investigate this issue, we injected fluorescently labeled STAT1 in living HeLa cells and traced them by single-molecule microscopy. We determined that STAT1 moved stochastically in the cytoplasm and nucleus with very short residence times (<0.03 s) before activation. Upon activation, STAT1 mobility in the cytoplasm decreased ∼2.5-fold, indicating reduced movement of STAT1/importinα/β complexes to the nucleus. In the nucleus, activated STAT1 displayed a distinct saltatory mobility, with residence times of up to 5 s and intermittent diffusive motion. In this manner, activated STAT1 factors can occupy their putative chromatin target sites within ∼2 s. These results provide a better understanding of the timescales on which cellular signaling and regulated gene transcription operate at the single-molecule level., (Copyright © 2011 Biophysical Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
20. SUMO conjugation of STAT1 protects cells from hyperresponsiveness to IFNγ.
- Author
-
Begitt A, Droescher M, Knobeloch KP, and Vinkemeier U
- Subjects
- Animals, Fibroblasts immunology, Fibroblasts metabolism, Gene Expression, Gene Knock-In Techniques, Immunoblotting, Interferon-gamma immunology, Macrophages immunology, Macrophages metabolism, Mice, Microscopy, Fluorescence, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction physiology, Gene Expression Regulation immunology, Interferon-gamma metabolism, STAT1 Transcription Factor metabolism, Sumoylation physiology
- Abstract
The biologic effects of IFNγ are mediated by the transcription factor STAT1. The activity of STAT1 is inhibited by small ubiquitin-like modifier (SUMO) conjugation. This occurs both directly through decreasing STAT1 tyrosine phosphorylation and indirectly by facilitating STAT1 dephosphorylation consequential to increased STAT1 solubility because of suppressed paracrystal assembly. However, the physiologic implications of SUMO conjugation have remained unclear. Here, we used fibroblasts and bone marrow-derived macrophages (BMMs) from knockin mice expressing SUMO-free STAT1 to explore the consequences of STAT1 sumoylation for IFNγ signaling. Our experiments demonstrated buffer property of paracrystals for activated STAT1, such that SUMO-mediated paracrystal dispersal profoundly reduced phosphorylation of STAT1, which affected both the activating tyrosine 701 and the transcription-enhancing serine 727. Accordingly, the curtailed STAT1 activity in the nucleus caused by SUMO conjugation resulted in diminished transcription of IFNγ-responsive genes; and increased the IFNγ concentration more than 100-fold required to trigger lipopolysaccharide-induced cytotoxicity in bone marrow-derived macrophages. These experiments identify SUMO conjugation of STAT1 as a mechanism to permanently attenuate the IFNγ sensitivity of cells, which prevents hyperresponsiveness to this cytokine and its potentially self-destructive consequences. This sets the mode of SUMO-mediated inhibition apart from the other negative STAT regulators known to date.
- Published
- 2011
- Full Text
- View/download PDF
21. STAT1 signaling is not regulated by a phosphorylation-acetylation switch.
- Author
-
Antunes F, Marg A, and Vinkemeier U
- Subjects
- Acetylation, Cell Line, Histone Deacetylase Inhibitors metabolism, Humans, Interferon-alpha metabolism, Interferon-gamma metabolism, Lysine metabolism, Mutation, Phosphorylation, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins metabolism, STAT1 Transcription Factor genetics, Histone Deacetylases metabolism, STAT1 Transcription Factor metabolism, Signal Transduction physiology
- Abstract
The treatment of cells with histone deacetylase inhibitors (HDACi) was reported to reveal the acetylation of STAT1 at lysine 410 and lysine 413 (O. H. Krämer et al., Genes Dev. 20:473-485, 2006). STAT1 acetylation was proposed to regulate apoptosis by facilitating binding to NF-κB and to control immune responses by suppressing STAT1 tyrosine phosphorylation, suggesting that STAT1 acetylation is a central mechanism by which histone deacetylase inhibitors ameliorate inflammatory diseases (O. H. Krämer et al., Genes Dev. 23:223-235, 2009). Here, we show that the inhibition of deacetylases had no bearing on STAT1 acetylation and did not diminish STAT1 tyrosine phosphorylation. The glutamine mutation of the alleged acetylation sites, claimed to mimic acetylated STAT1, similarly did not diminish the tyrosine phosphorylation of STAT1 but precluded its DNA binding and nuclear import. The defective transcription activity of this mutant therefore cannot be attributed to STAT1 acetylation but rather to the inactivation of the STAT1 DNA binding domain and its nuclear import signal. Experiments with respective cDNAs provided by the authors of the studies mentioned above confirmed the results reported here, further questioning the validity of the previous data. We conclude that the effects and potential clinical benefits associated with histone deacetylase inhibition cannot be explained by promoting the acetylation of STAT1 at lysines 410 and 413.
- Published
- 2011
- Full Text
- View/download PDF
22. Paracrystals of STAT proteins and their dissolution by SUMO: how reduced transcription factor solubility increases cytokine signaling.
- Author
-
Droescher M, Begitt A, and Vinkemeier U
- Subjects
- Animals, Cell Nucleus, Crystallization, Mice, STAT1 Transcription Factor chemistry, Solubility, Ubiquitination, Cytokines metabolism, Protein Multimerization, STAT1 Transcription Factor metabolism, Signal Transduction, Small Ubiquitin-Related Modifier Proteins metabolism
- Published
- 2011
- Full Text
- View/download PDF
23. Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO).
- Author
-
Droescher M, Begitt A, Marg A, Zacharias M, and Vinkemeier U
- Subjects
- Animals, HeLa Cells, Humans, Mice, STAT1 Transcription Factor genetics, STAT3 Transcription Factor genetics, SUMO-1 Protein genetics, Signal Transduction physiology, Solubility, Cytokines metabolism, Models, Biological, Protein Multimerization physiology, STAT1 Transcription Factor metabolism, STAT3 Transcription Factor metabolism, SUMO-1 Protein metabolism
- Abstract
The biological effects of cytokines are mediated by STAT proteins, a family of dimeric transcription factors. In order to elicit transcriptional activity, the STATs require activation by phosphorylation of a single tyrosine residue. Our experiments revealed that fully tyrosine-phosphorylated STAT dimers polymerize via Tyr(P)-Src homology 2 domain interactions and assemble into paracrystalline arrays in the nucleus of cytokine-stimulated cells. Paracrystals are demonstrated to be dynamic reservoirs that protect STATs from dephosphorylation. Activated STAT3 forms such paracrystals in acute phase liver cells. Activated STAT1, in contrast, does not normally form paracrystals. By reversing the abilities of STAT1 and STAT3 to be sumoylated, we show that this is due to the unique ability of STAT1 among the STATs to conjugate to small ubiquitin-like modifier (SUMO). Sumoylation had one direct effect; it obstructed proximal tyrosine phosphorylation, which led to semiphosphorylated STAT dimers. These competed with their fully phosphorylated counterparts and interfered with their polymerization into paracrystals. Consequently, sumoylation, by preventing paracrystal formation, profoundly curtailed signal duration and reporter gene activation in response to cytokine stimulation of cells. The study thus identifies polymerization of activated STAT transcription factors as a positive regulatory mechanism in cytokine signaling. It provides a unifying explanation for the different subnuclear distributions of STAT transcription factors and reconciles the conflicting results as to the role of SUMO modification in STAT1 functioning. We present a generally applicable system in which protein solubility is maintained by a disproportionately small SUMO-modified fraction, whereby modification by SUMO partially prevents formation of polymerization interfaces, thus generating competitive polymerization inhibitors.
- Published
- 2011
- Full Text
- View/download PDF
24. Molecular basis for the recognition of phosphorylated STAT1 by importin alpha5.
- Author
-
Nardozzi J, Wenta N, Yasuhara N, Vinkemeier U, and Cingolani G
- Subjects
- Active Transport, Cell Nucleus, Amino Acid Sequence, Binding Sites, Cell Nucleus metabolism, Humans, Models, Molecular, Molecular Sequence Data, Mutation genetics, Nuclear Localization Signals, Peptide Fragments genetics, Peptide Fragments metabolism, Phosphorylation, Protein Binding, Protein Conformation, STAT1 Transcription Factor genetics, Sequence Homology, Amino Acid, Surface Plasmon Resonance, alpha Karyopherins genetics, STAT1 Transcription Factor chemistry, STAT1 Transcription Factor metabolism, alpha Karyopherins chemistry, alpha Karyopherins metabolism
- Abstract
Interferon-gamma stimulation triggers tyrosine phosphorylation of the transcription factor STAT1 at position 701, which is associated with switching from carrier-independent nucleocytoplasmic shuttling to carrier-mediated nuclear import. Unlike most substrates that carry a classical nuclear localization signal (NLS) and bind to importin alpha1, STAT1 possesses a nonclassical NLS recognized by the isoform importin alpha5. In the present study, we have analyzed the mechanisms by which importin alpha5 binds phosphorylated STAT1 (pSTAT1). We found that a homodimer of pSTAT1 is recognized by one equivalent of importin alpha5 with K(d)=191+/-20 nM. Whereas tyrosine phosphorylation at position 701 is essential to assemble a pSTAT1-importin alpha5 complex, the phosphate moiety is not a direct binding determinant for importin alpha5. In contrast to classical NLS substrates, pSTAT1 binding to importin alpha5 is not displaced by the N-terminal importin beta binding domain and requires the importin alpha5 C-terminal acidic tail (505-EEDD-508). A local unfolding of importin alpha5 Armadillo (ARM) repeat 10 accompanies high-affinity binding to pSTAT1. This unfolding is mediated by a single conserved tyrosine at position 476 of importin alpha5, which is inserted between ARM repeat 10 helices H1-H2-H3, thereby preventing intramolecular helical stacking essential to stabilize the folding conformation of ARM 10. Introducing a glycine at this position, as in importin alpha1, disrupts high-affinity binding to pSTAT1, suggesting that pSTAT1 recognition is dependent on the intrinsic flexibility of ARM 10. Using the quantitative stoichiometry and binding data presented in this article, together with mutational information available in the literature, we propose that importin alpha5 binds between two STAT1 monomers, with two major binding determinants in the SH2 and DNA binding domains. In vitro, this model is supported by the observation that a 38-mer DNA oligonucleotide containing two tandem cfosM67 promoters can displace importin alpha5 from pSTAT1, suggesting a possible role for DNA in releasing activated STAT1 in the cell nucleus., (Copyright 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
25. Assessing sequence-specific DNA binding and transcriptional activity of STAT1 transcription factor.
- Author
-
Meyer T and Vinkemeier U
- Subjects
- Animals, Base Sequence, Biotinylation, Blotting, Western, Cell Line, Tumor, Electrophoretic Mobility Shift Assay, Fluorescence Recovery After Photobleaching, Genes, Reporter genetics, Humans, Immunohistochemistry, Interferons metabolism, Janus Kinases metabolism, Microscopy, Fluorescence, Permeability, Phosphorylation, Plasmids genetics, Recombinant Proteins isolation & purification, Recombinant Proteins metabolism, STAT1 Transcription Factor isolation & purification, Signal Transduction, Substrate Specificity, DNA genetics, DNA metabolism, STAT1 Transcription Factor metabolism, Transcription, Genetic
- Abstract
Continuous nucleocytoplasmic shuttling of signal transducer and activator of transcription (STAT) proteins is a key to understand their function as cytokine-responsive transcription factors. STATs enter the nucleus both by carrier-dependent and carrier-independent transport pathways, and it was previously shown that STAT1 exits the nucleus only after its prior enzymatic dephosphorylation by nuclear phosphatases. The identification of different transport pathways for unphosphorylated and tyrosine-phosphorylated STAT dimers was made possible by a combination of a diverse set of experimental approaches in the field of molecular biology. In the following, we will summarize some of the techniques that have been successfully used to decipher molecular mechanisms engaged in STAT1 dynamics.
- Published
- 2010
- Full Text
- View/download PDF
26. Microinjected antibodies interfere with protein nucleocytoplasmic shuttling by distinct molecular mechanisms.
- Author
-
Marg A, Meyer T, Vigneron M, and Vinkemeier U
- Subjects
- Antibodies immunology, Green Fluorescent Proteins immunology, HeLa Cells, Humans, Interferon-gamma metabolism, Microinjections, STAT1 Transcription Factor immunology, STAT1 Transcription Factor metabolism, alpha Karyopherins immunology, alpha Karyopherins metabolism, beta Karyopherins immunology, beta Karyopherins metabolism, Active Transport, Cell Nucleus physiology, Antibodies metabolism, Cell Nucleus metabolism, Cytoplasm metabolism, Green Fluorescent Proteins metabolism
- Abstract
The observation that some antibodies can enter the nucleus after their microinjection into the cytoplasm established the principle of protein nucleocytoplasmic shuttling. Here, we introduce the concept of stationary antibodies for studying nuclear transport, particularly of native proteins. Contrary to the aforementioned translocating immunoglobulins, stationary antibodies do not cross the nuclear envelope. They are distinguished by their ability to trigger the nucleocytoplasmic redistribution of their antigen. What determines these apparently contradictory outcomes has not been explored. We studied a stationary STAT1 antibody and a translocating importin-beta antibody. The stationary phenotype resulted from the inhibition of carrier-independent transport. This was not due to crosslinking or precipitation of antigen, because the antigen-antibody complex remained highly mobile. Rather, decoration with stationary antibody precluded actual nuclear pore passage of antigen. In addition, both antibodies inhibited the carrier-dependent translocation via importin-alpha, but by diverse mechanisms. The translocating antibody blocked the association with importin-alpha, whereas the stationary antibody prevented the phosphorylation of its antigen, and thus functioned upstream of the importin-alpha binding step. We identified a stationary antibody to green-fluorescent protein (GFP) and probed the translocation of GFP fusions of STAT1, thyroid hormone receptor and histones, demonstrating general application of this approach. Our results provide an experimental rationale for the use of antibodies as unique tools for dissecting protein nuclear translocation. As the microinjection of stationary antibodies extends to analyses of native proteins, this method can complement and validate results obtained with fluorescent-labeled derivatives.
- Published
- 2008
- Full Text
- View/download PDF
27. Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations.
- Author
-
Wenta N, Strauss H, Meyer S, and Vinkemeier U
- Subjects
- Conserved Sequence, DNA metabolism, Dimerization, Humans, Models, Molecular, Phosphorylation, Protein Binding, Protein Structure, Quaternary, Protein Structure, Tertiary, Thermodynamics, Phosphotyrosine metabolism, STAT1 Transcription Factor chemistry, STAT1 Transcription Factor metabolism
- Abstract
The activation/inactivation cycle of STAT transcription factors entails their transition between different dimer conformations. Unphosphorylated STATs can dimerize in an antiparallel conformation via extended interfaces of the globular N-domains, whereas STAT activation triggers a parallel dimer conformation with mutual phosphortyrosine:SH2 domain interactions, resulting in DNA-binding and nuclear retention. However, despite the crucial role of STAT tyrosine phosphorylation in cytokine signaling, it has not been determined how this modification affects the stability and the conformational flexibility of STAT dimers. Here, we use analytical ultracentrifugation and electrophoretic mobility shift assay (EMSA) to study the association of STAT1 in solution before and after tyrosine phosphorylation. It is revealed that STAT1 formed high-affinity dimers (K(d) of approximately 50 nM) with estimated half-lives of 20-40 min irrespective of the phosphorylation status. Our results demonstrate that parallel and antiparallel conformations of STAT1 were present simultaneously, supported by mutually exclusive interfaces; and the transition between conformations occurred through affinity-driven dissociation/association reactions. Therefore, tyrosine phosphorylation was dispensable for DNA binding, but the phosphorylation enforced preformed SH2 domain-mediated dimers, thus enhancing the DNA-binding activity of STAT1 >200-fold. Moreover, upon STAT1 activation the N-domains adopted an open conformation and engaged in interdimer interactions, as demonstrated by their participation in tetramerization instead of dimerization. Yet, homotypic N-domain interactions are not conserved in the STAT family, because the N-domain dissociation constants of STAT1, STAT3, and STAT4 differed by more than three orders of magnitude. In conclusion, STAT1 constantly oscillated between different dimer conformations, whereby the abundance of the dimerization interfaces was determined by tyrosine phosphorylation.
- Published
- 2008
- Full Text
- View/download PDF
28. Dysferlin-deficient muscular dystrophy features amyloidosis.
- Author
-
Spuler S, Carl M, Zabojszcza J, Straub V, Bushby K, Moore SA, Bähring S, Wenzel K, Vinkemeier U, and Rocken C
- Subjects
- Adult, Aged, Amino Acid Sequence, Amino Acid Substitution genetics, Amyloidosis diagnosis, Dysferlin, Female, Humans, Male, Middle Aged, Molecular Sequence Data, Muscular Dystrophies, Limb-Girdle diagnosis, Protein Structure, Tertiary genetics, Amyloidosis genetics, Amyloidosis metabolism, Membrane Proteins deficiency, Membrane Proteins genetics, Muscle Proteins deficiency, Muscle Proteins genetics, Muscular Dystrophies, Limb-Girdle genetics, Muscular Dystrophies, Limb-Girdle metabolism
- Abstract
Objective: Dysferlin (DYSF) gene mutations cause limb girdle muscular dystrophy type 2B and Miyoshi's myopathy. The consequences of DYSF mutations on protein structure are poorly understood., Methods: The gene encoding dysferlin was sequenced in patients with suspected dysferlin-deficient muscular dystrophy. Muscle biopsy specimens were analyzed by histochemistry, immunohistochemistry, and electron microscopy. Antibodies against N-terminal dysferlin-peptides were raised., Results: We found three families with muscular dystrophy caused by homozygous or compound heterozygous DYSF mutations featuring sarcolemmal and interstitial amyloid deposits. These mutations were all located in the N-terminal region of the protein. Dysferlin was a constituent of the amyloid deposits., Interpretation: Limb girdle muscular dystrophy type 2B is the first muscular dystrophy associated with amyloidosis. Molecular treatment strategies will necessarily have to consider the presence of amyloidogenesis.
- Published
- 2008
- Full Text
- View/download PDF
29. STAT nuclear translocation: potential for pharmacological intervention.
- Author
-
Meyer T and Vinkemeier U
- Subjects
- Animals, Cell Nucleus drug effects, Cytokines administration & dosage, Humans, Protein Transport drug effects, Protein Transport physiology, STAT Transcription Factors genetics, Signal Transduction drug effects, Signal Transduction physiology, Transcription, Genetic drug effects, Cell Nucleus metabolism, Pharmaceutical Preparations administration & dosage, STAT Transcription Factors metabolism, Transcription, Genetic physiology
- Abstract
The signal transducer and activator of transcription (STAT) proteins are extracellular ligand-responsive transcription factors that mediate broadly diverse biological processes, including cell proliferation, transformation, apoptosis, differentiation, fetal development, inflammation and immune response. Stimulation with multiple cytokines or growth factors all result in the tyrosine phosphorylation of STAT proteins and the subsequent gene regulation via their direct binding to the promoters of responsive genes. Cytokine-regulated gene activation is dependent on the continuous nucleocytoplasmic cycling of STAT signal transducers. The STATs use intricately intertwined karyopherin-dependent and -independent translocation mechanisms to coordinate the activation step at the cell membrane and gene expression in the nucleus. In addition, STATs appear to have cytokine-independent gene regulatory functions that may also depend on their regulated nucleocytoplasmic transfer. Numerous studies have implicated aberrant STAT signalling in cancer, immune defects and inflammatory diseases. Given the central role of intracellular trafficking for the proper signal processing by STAT proteins, pharmacological targeting of STAT nucleocytoplasmic translocation appears to be an attractive strategy to interfere with dysregulated cytokine signalling. This review will discuss possible scenarios that would result from the use of novel modulators of STAT shuttling, which may both increase or decrease STAT activation and, hence, transcriptional activity.
- Published
- 2007
- Full Text
- View/download PDF
30. Green fluorescent protein-tagging reduces the nucleocytoplasmic shuttling specifically of unphosphorylated STAT1.
- Author
-
Meyer T, Begitt A, and Vinkemeier U
- Subjects
- Active Transport, Cell Nucleus, Blotting, Western, Cell Line, Cytoplasm metabolism, Electrophoretic Mobility Shift Assay, Green Fluorescent Proteins genetics, HeLa Cells, Humans, Immunohistochemistry, Kinetics, Microscopy, Fluorescence, Phosphorylation, Protein Binding, Recombinant Fusion Proteins genetics, STAT1 Transcription Factor genetics, Transcription, Genetic, Transfection, Tyrosine metabolism, Cell Nucleus metabolism, Green Fluorescent Proteins metabolism, Recombinant Fusion Proteins metabolism, STAT1 Transcription Factor metabolism
- Abstract
Fluorescence recovery after photobleaching (FRAP) and related techniques using green fluorescent protein (GFP)-tagged proteins are widely used to study the subcellular trafficking of proteins. It was concluded from these experiments that the cytokine-induced nuclear import of tyrosine-phosphorylated (activated) signal transducer and activator of transcription 1 (STAT1) was rapid, while the constitutive shuttling of unphosphorylated STAT1 was determined to be inefficient. However, unrelated experiments came to different conclusions concerning the constitutive translocation of STAT1. Because these discrepancies have not been resolved, it remained unclear whether or not unphosphorylated STAT1 is a relevant regulator of cytokine-dependent gene expression. This study was initiated to examine the influence of GFP-tagging on the nucleocytoplasmic shuttling of phosphorylated and unphosphorylated STAT1. In accordance with previous findings our results confirm the undisturbed rapid nuclear import of GFP-tagged activated STAT1. However, we reveal an inhibitory influence of GFP specifically on the constitutive nucleocytoplasmic cycling of the unphosphorylated protein. The decreased shuttling of unphosphorylated STAT1-GFP significantly reduced the activation level while nuclear accumulation was prolonged. Importantly, despite unimpaired nuclear import of activated STAT1 the transcription of a STAT1-dependent reporter gene was more than halved after GFP-tagging, which could be linked directly to reduced nucleocytoplasmic shuttling. In conclusion, it is demonstrated that GFP-based techniques considerably underestimate the actual shuttling rate of unphosphorylated native STAT1. The results confirm that the activation of STAT1 and hence its transcriptional activity is proportional to the nucleocytoplasmic shuttling rate of the unphosphorylated protein. Moreover, our data indicate that GFP-tagging may differently affect the mechanistically distinct translocation pathways of a shuttling protein.
- Published
- 2007
- Full Text
- View/download PDF
31. Nuclear export determines the cytokine sensitivity of STAT transcription factors.
- Author
-
Lödige I, Marg A, Wiesner B, Malecová B, Oelgeschläger T, and Vinkemeier U
- Subjects
- Alternative Splicing, Blotting, Western, Cell Nucleus metabolism, Cytoplasm metabolism, Dimerization, Dose-Response Relationship, Drug, Genes, Reporter, Glutathione Transferase metabolism, Green Fluorescent Proteins chemistry, HeLa Cells, Humans, Microscopy, Confocal, Models, Biological, Peptides chemistry, Phosphorylation, Plasmids metabolism, Protein Structure, Tertiary, Recombinant Proteins chemistry, STAT1 Transcription Factor metabolism, Serine chemistry, Time Factors, Transcription, Genetic, Transcriptional Activation, Tyrosine chemistry, src Homology Domains, Active Transport, Cell Nucleus, Cytokines metabolism, STAT Transcription Factors metabolism
- Abstract
Cytokine-dependent gene activation critically depends upon the tyrosine phosphorylation (activation) of STAT transcription factors at membrane-bound cytokine receptors. The extent of STAT activation and hence the specificity of signaling is primarily determined by structural complementarity between the SH2 domain of the STATs and the tyrosine-phosphorylated receptor chains. Here, we identified constitutive nucleocytoplasmic shuttling as another mechanism that controls the differential activation of STAT transcription factors. Our analysis of nucleocytoplasmic cycling of STAT1 revealed that the expression of the alternatively spliced transactivation domain and its signal-dependent serine phosphorylation maximized the rate of nuclear export. Export modulation occurred independently of retention factors or the export receptor CRM1, and was observed both before and during stimulation of cells with cytokines. Our data indicated a dual role for the transactivation domain. It enhanced the nuclear retention of activated STAT1, but had the opposite effect on inactivated molecules. Accordingly, and despite their identical receptor recognition, the STAT1 splice variants differed strongly in the amplitude of tyrosine phosphorylation and in the duration of the cytokine signal. Thus, regulated nuclear export determined the cytokine sensitivity of the shuttling STAT1 transcription factors by controlling their availability at the receptor kinase complex.
- Published
- 2005
- Full Text
- View/download PDF
32. Antiviral activity of oligomerization-deficient Stat1.
- Author
-
Vinkemeier U and Meyer T
- Subjects
- Antiviral Agents pharmacology, Binding Sites, Cell Culture Techniques, Cell Line, Cell Line, Transformed, Cell Nucleus metabolism, Cell Survival drug effects, Cell Transformation, Viral, Dimerization, Humans, Interferon-Stimulated Gene Factor 3, gamma Subunit metabolism, Interferon-alpha pharmacology, Interferon-gamma pharmacology, Phosphorylation, Point Mutation, Promoter Regions, Genetic, Protein Binding, Protein Structure, Tertiary genetics, STAT1 Transcription Factor chemistry, STAT1 Transcription Factor deficiency, STAT2 Transcription Factor metabolism, Time Factors, Trans-Activators genetics, Tyrosine metabolism, Vesicular stomatitis Indiana virus drug effects, Virus Replication, Cytopathogenic Effect, Viral genetics, STAT1 Transcription Factor genetics, STAT1 Transcription Factor metabolism, Trans-Activators metabolism
- Abstract
Interferon stimulation of cells can activate several hundred target genes, many of which are required for antiviral protection. Promoter binding of tyrosine-phosphorylated (activated) Stat1 dimers is essential for gene induction, a process that often entails the oligomerization of Stat1 dimers via interactions of their aminoterminal domains. The mutation of a single residue (F77) in the N-domain of Stat1 was recently demonstrated to preclude both the dephosphorylation and the oligomerization of Stat1 dimers. Here, we investigated the influence of defective oligomerization on a complex phenotype such as the induction of an antiviral state. It was found that the antiviral protection conferred by interferon-a was strongly reduced, whereas the interferon-g response was not measurably affected. These results indicate that Stat1 oligomerization is required for the antiviral activity of interferons. Moreover, the concentration of activated Stat1 in the nucleus may generally play a critical role for interferon-induced target gene activation.
- Published
- 2005
33. Nucleocytoplasmic shuttling of STAT transcription factors.
- Author
-
Meyer T and Vinkemeier U
- Subjects
- Biological Transport, Cytokines metabolism, Cytokines physiology, Humans, Signal Transduction, Cell Nucleus metabolism, Cytoplasm metabolism, Transcription Factors metabolism
- Abstract
The signal transducer and activator of transcription (STAT) proteins have initially been described as cytoplasmic proteins that enter the nucleus only after cytokine treatment of cells. Contrary to this assumption, it was demonstrated that STATs are constantly shuttling between nucleus and cytoplasm irrespective of cytokine stimulation. This happens both via carrier-dependent as well as carrier-independent transportation. Moreover, it was also recognized that cytokine stimulation triggers nuclear retention of dimeric STATs, rather than affecting the rate of nuclear import. In summary, it is increasingly being appreciated that STAT nucleocytoplasmic cycling determines the quality of cytokine signaling and also constitutes an important area for microbial intervention.
- Published
- 2004
- Full Text
- View/download PDF
34. Arginine methylation of STAT1: a reassessment.
- Author
-
Meissner T, Krause E, Lödige I, and Vinkemeier U
- Subjects
- Artifacts, Humans, Interferons metabolism, Methylation, Mutation genetics, Reproducibility of Results, STAT1 Transcription Factor, Arginine metabolism, DNA-Binding Proteins metabolism, Methyltransferases metabolism, Neoplasms metabolism, Trans-Activators metabolism
- Published
- 2004
- Full Text
- View/download PDF
35. Getting the message across, STAT! Design principles of a molecular signaling circuit.
- Author
-
Vinkemeier U
- Subjects
- Active Transport, Cell Nucleus, Animals, Cytokines metabolism, DNA metabolism, Humans, Milk Proteins, Models, Biological, Mutation, Phosphorylation, Protein Structure, Tertiary, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor, Signal Transduction, Transcription, Genetic, DNA-Binding Proteins physiology, Trans-Activators physiology
- Abstract
The STAT transcription factors, usually referred to as "latent cytoplasmic proteins," have experienced a fundamental reevaluation of their dynamic properties. This review focuses on recent studies that have identified continuous transport factor-independent nucleocytoplasmic cycling of STAT1, STAT3, and STAT5 as a basic principle of cytokine signaling. In addition, molecular mechanisms that modulate flux rates or cause retention were recognized, and together these findings have provided novel insight into the rules of cellular signal processing.
- Published
- 2004
- Full Text
- View/download PDF
36. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
- Author
-
Meissner T, Krause E, and Vinkemeier U
- Subjects
- Active Transport, Cell Nucleus physiology, Alkylation, Amino Acid Substitution, Cell Nucleus drug effects, Cell Nucleus metabolism, Cysteine chemistry, Glutathione Transferase metabolism, HeLa Cells, Humans, Karyopherins chemistry, Karyopherins drug effects, Karyopherins genetics, Karyopherins metabolism, Microinjections, Receptors, Cytoplasmic and Nuclear chemistry, Receptors, Cytoplasmic and Nuclear drug effects, Receptors, Cytoplasmic and Nuclear genetics, Receptors, Cytoplasmic and Nuclear metabolism, Recombinant Fusion Proteins metabolism, Serine metabolism, Exportin 1 Protein, Active Transport, Cell Nucleus drug effects, Antifungal Agents pharmacology, Fatty Acids, Unsaturated pharmacology, Karyopherins antagonists & inhibitors, Pyrones metabolism, Receptors, Cytoplasmic and Nuclear antagonists & inhibitors
- Abstract
Research on the export of proteins and nucleic acids from the nucleus to the cytoplasm has greatly gained from the discovery that the actinobacterial toxin leptomycin B (LMB) specifically inactivates the export receptor chromosomal region maintenance 1 (CRM1). Recently, it was shown that myxobacterial cytotoxins, named ratjadones (RATs), also bind to CRM1 and inhibit nuclear export. However, the reaction mechanism of RATs was not resolved. Here, we show that LMB and RAT A employ the same molecular mechanism to inactivate CRM1. Alkylation of residue Cys528 of CRM1 determines both LMB and RAT sensitivity and prevents nuclear export of CRM1 cargo proteins., (Copyright 2004 Federation of European Biochemical Societies)
- Published
- 2004
- Full Text
- View/download PDF
37. Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1.
- Author
-
Marg A, Shan Y, Meyer T, Meissner T, Brandenburg M, and Vinkemeier U
- Subjects
- 3T3 Cells, Active Transport, Cell Nucleus physiology, Animals, COS Cells, Chlorocebus aethiops, Cytoplasm physiology, HeLa Cells, Humans, Mice, Microscopy, Fluorescence, Mutagenesis, Plasmids, Protein Transport, Recombinant Proteins metabolism, STAT1 Transcription Factor, Subcellular Fractions metabolism, Zinc Fingers, Exportin 1 Protein, Cell Nucleus physiology, DNA-Binding Proteins metabolism, Karyopherins metabolism, Nuclear Pore Complex Proteins metabolism, Receptors, Cytoplasmic and Nuclear, Trans-Activators metabolism
- Abstract
Interferon stimulation of cells leads to the tyrosine phosphorylation of latent Stat1 and subsequent transient accumulation in the nucleus that requires canonical transport factors. However, the mechanisms that control the predominantly cytoplasmic localization in unstimulated cells have not been resolved. We uncovered that constitutive energy- and transport factor-independent nucleocytoplasmic shuttling is a property of unphosphorylated Stat1, Stat3, and Stat5. The NH(2)- and COOH-terminal Stat domains are generally dispensable, whereas alkylation of a single cysteine residue blocked cytokine-independent nuclear translocation and thus implicated the linker domain into the cycling of Stat1. It is revealed that constitutive nucleocytoplasmic shuttling of Stat1 is mediated by direct interactions with the FG repeat regions of nucleoporin 153 and nucleoporin 214 of the nuclear pore. Concurrent active nuclear export by CRM1 created a nucleocytoplasmic Stat1 concentration gradient that is significantly reduced by the blocking of energy-requiring translocation mechanisms or the specific inactivation of CRM1. Thus, we propose that two independent translocation pathways cooperate to determine the steady-state distribution of Stat1.
- Published
- 2004
- Full Text
- View/download PDF
38. A single residue modulates tyrosine dephosphorylation, oligomerization, and nuclear accumulation of stat transcription factors.
- Author
-
Meyer T, Hendry L, Begitt A, John S, and Vinkemeier U
- Subjects
- Cell Nucleus chemistry, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Dimerization, Gene Expression Regulation, HeLa Cells, Humans, Mutagenesis, Site-Directed, Nuclear Proteins analysis, Phosphorylation, STAT1 Transcription Factor, STAT5 Transcription Factor, Trans-Activators genetics, Trans-Activators metabolism, Transcription Factors genetics, Transfection, Tumor Suppressor Proteins, Cell Nucleus metabolism, Milk Proteins, Phosphotyrosine metabolism, Transcription Factors metabolism
- Abstract
The NH(2) terminus of Stat proteins forms a versatile protein interaction domain that is believed to use discrete surfaces to mediate oligomerization and tyrosine dephosphorylation of Stat dimers. Here we show for Stat1 and Stat5a/b that these interfaces overlap and need to be reassigned to an unrelated region of the N-domain. Unexpectedly, our study showed for Stat1 that defective oligomerization of DNA-bound dimers was associated with prolonged interferon-induced nuclear accumulation. This uncoupling of DNA binding and nuclear retention was explained by the concomitant dephosphorylation deficiency that both Stat1 and Stat5a/b have in common and that for Stat1 was due to defective dephosphorylation by the phosphatase TC45. Furthermore, diminished N-domain-mediated oligomerization affected transcriptional activation by both Stat1 and Stat5a/b in a promoter-specific manner. DNA binding analysis indicated that oligomerization of Stats on DNA may be common, irrespective of the presence of multiple canonical binding sites. Accordingly, also transcription from promoters with only a single discernable gamma-activated sequence site was negatively effected by reduced tetramerization. Thus, these results indicate that defective oligomerization cannot generally be compensated for by enhanced tyrosine phosphorylation and prolonged nuclear accumulation. In addition, these data clarify the role of DNA binding in nuclear retention of Stat1.
- Published
- 2004
- Full Text
- View/download PDF
39. DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.
- Author
-
Meyer T, Marg A, Lemke P, Wiesner B, and Vinkemeier U
- Subjects
- Active Transport, Cell Nucleus, Antibodies, Monoclonal metabolism, Cytoplasm metabolism, DNA-Binding Proteins chemistry, DNA-Binding Proteins drug effects, DNA-Binding Proteins genetics, Enzyme Inhibitors pharmacology, HeLa Cells, Humans, Interferon-gamma pharmacology, Models, Biological, Mutation, Phosphorylation, Recombinant Proteins isolation & purification, Recombinant Proteins metabolism, STAT1 Transcription Factor, Trans-Activators chemistry, Trans-Activators drug effects, Trans-Activators genetics, Transcription, Genetic, Transcriptional Activation, Tumor Cells, Cultured, Tyrosine metabolism, Vanadates pharmacology, Cell Nucleus metabolism, DNA metabolism, DNA-Binding Proteins metabolism, Trans-Activators metabolism
- Abstract
Cytokine-dependent gene transcription greatly depends on the tyrosine phosphorylation ("activation") of Stat proteins at the cell membrane. This rapidly leads to their accumulation in the nucleus by an unknown mechanism. We performed microinjections of recombinant Stat1 protein to show that nuclear accumulation of phosphorylated Stat1 can occur without cytokine stimulation of cells. Microinjection of Stat1 antibody and treatment of cells with kinase or phosphatase inhibitors revealed that nuclear accumulation is a highly dynamic process sustained by Stat1 nucleocytoplasmic cycling and continuous kinase activity. By characterizing nuclear accumulation mutants, it is demonstrated that nuclear import and nuclear retention are two separate steps leading up to nuclear accumulation, with nonspecific DNA binding of activated Stat1 being sufficient for nuclear retention. Critical for nuclear buildup of Stat1 and the subsequent nuclear export is the point of time of tyrosine dephosphorylation, because our data indicate that activated Stat1 is incapable of leaving the nucleus and requires dephosphorylation to do so. It is demonstrated that the inactivation of Stat1 is controlled by its exchange reaction with DNA, whereby DNA binding protects Stat1 from dephosphorylation in a sequence-specific manner. Thus, during nuclear accumulation, a surprisingly simple mechanism integrates central aspects of cytokine-dependent gene regulation, for example, receptor monitoring, promoter occupancy, and transcription factor inactivation.
- Published
- 2003
- Full Text
- View/download PDF
40. A reinterpretation of the dimerization interface of the N-terminal domains of STATs.
- Author
-
Chen X, Bhandari R, Vinkemeier U, Van Den Akker F, Darnell JE Jr, and Kuriyan J
- Subjects
- Binding Sites, Circular Dichroism, DNA-Binding Proteins genetics, Dimerization, Humans, Models, Molecular, Mutation genetics, Protein Binding, Protein Structure, Tertiary, Recombinant Proteins chemistry, Recombinant Proteins metabolism, STAT4 Transcription Factor, Trans-Activators genetics, Ultracentrifugation, DNA-Binding Proteins chemistry, DNA-Binding Proteins metabolism, Trans-Activators chemistry, Trans-Activators metabolism
- Abstract
The crystal structures of the N-terminal domain (N-domain) and the core region of the STAT family of transcription factors have been determined previously. STATs can form cooperative higher order structures (tetramers or higher oligomers) while bound to DNA. The crystal packing in the STAT4 N-domain crystal structure, determined at 1.5 A resolution, suggests two alternate organizations of the N-domain dimer. We now present the results of site directed mutagenesis of residues predicted to be involved at each dimer interface. Our results indicate that the dimer interface suggested earlier as being physiologically relevant is, in fact, unlikely to be so. Given the alternative model for the N-domain dimer, the ability of the N-domain to mediate interactions of two STAT dimers on DNA remains unchanged.
- Published
- 2003
- Full Text
- View/download PDF
41. [Assessment of the ethical consequences of genotype-based pharmacotherapy].
- Author
-
Meyer T, Vinkemeier U, and Meyer U
- Subjects
- Humans, Patient Rights, Physician-Patient Relations, Drug Therapy ethics, Genotype, Pharmacogenetics ethics
- Published
- 2002
- Full Text
- View/download PDF
42. Constitutive and IFN-gamma-induced nuclear import of STAT1 proceed through independent pathways.
- Author
-
Meyer T, Begitt A, Lödige I, van Rossum M, and Vinkemeier U
- Subjects
- Amino Acid Sequence, Animals, Binding Sites genetics, DNA-Binding Proteins genetics, HeLa Cells, Humans, Interferon-gamma pharmacology, Mice, Molecular Sequence Data, Phosphorylation, Protein Transport drug effects, STAT1 Transcription Factor, Sequence Alignment, Signal Transduction physiology, Trans-Activators genetics, Cell Nucleus metabolism, DNA-Binding Proteins metabolism, Protein Transport physiology, Trans-Activators metabolism
- Abstract
STAT1 functions as both a constitutive transcriptional regulator and, in response to cytokine stimulation of cells, as an inducible tyrosine-phosphorylated transcription factor. Here, we identify and characterize a non-transferable nuclear targeting sequence in the STAT1 DNA-binding domain. This conserved signal is critical for the interferon-gamma (IFN-gamma)-induced nuclear import of phosphorylated STAT1 dimers and requires adjacent positively charged and hydrophobic residues for functioning. Additionally, the constitutive nucleocytoplasmic shuttling of STAT1 in the absence of IFN-gamma stimulation is revealed. Nuclear import and export of unphosphorylated STAT1 are demonstrated to be sensitive towards wheat germ agglutinin and to occur independently of the import receptor p97. Loss-of-function mutations of the dimer-specific import signal block nuclear entry of tyrosine-phosphorylated STAT1, which in turn also prevents induction of cytokine-inducible target genes. Nevertheless, nuclear import of unphosphorylated STAT1 continues and the STAT1-dependent constitutive expression of caspases and the tumor necrosis factor-alpha-mediated induction of apoptosis proceed unaltered. Thus, tyrosine-phosphorylated and unphosphorylated STAT1 molecules shuttle via independent pathways to distinct sets of target genes.
- Published
- 2002
- Full Text
- View/download PDF
43. Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3.
- Author
-
Meyer T, Gavenis K, and Vinkemeier U
- Subjects
- Cell Line, Transformed, DNA-Binding Proteins genetics, Enzyme Inhibitors pharmacology, Humans, Mutation, Organ Specificity, Phosphorylation, Protein-Tyrosine Kinases antagonists & inhibitors, Protein-Tyrosine Kinases metabolism, STAT1 Transcription Factor, STAT3 Transcription Factor, Signal Transduction, Staurosporine pharmacology, Trans-Activators genetics, Tyrosine, Cell Nucleus metabolism, DNA-Binding Proteins metabolism, Trans-Activators metabolism
- Abstract
Tyrosine phosphorylation in response to cytokine stimulation of cells is believed to be required for the nuclear translocation of cytoplasmic STAT proteins (signal transducers and activators of transcription). In this study we examined the nucleocytoplasmic distribution of STAT1 and STAT3 in transformed cell lines and primary cells prior to stimulation with cytokines. It was found that both STAT1 and STAT3 are constitutively nuclear in resting cells. Moreover, the extent of nuclear presence of both proteins differed in a cell type-specific mode as revealed by immunocytochemistry and confocal microscopy. We investigated whether varying degrees of tyrosine phosphorylation could account for these differences. The results show that depletion of type I interferons from culture medium with blocking antibodies did not influence the STAT1 distribution in unstimulated cells. In addition, blocking tyrosine kinase activity with staurosporine also did not influence the nucleocytoplasmic STAT1 distribution in resting cells. Nuclear extracts from unstimulated HeLa-S3 cells, which are demonstrated to be exceptionally high in the nuclear concentration of STAT1, did not contain detectable quantities of tyrosine-phosphorylated STAT1. In addition, the nucleocytoplasmic distribution of a STAT1 mutant which can no longer be phosphorylated or dimerize did not differ from wild-type protein. Thus, these data indicate that tyrosine phosphorylation of STATs does not constitute a mandatory requirement for the nuclear presence of these transcription factors.
- Published
- 2002
- Full Text
- View/download PDF
44. Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain.
- Author
-
Begitt A, Meyer T, van Rossum M, and Vinkemeier U
- Subjects
- Amino Acid Sequence, Base Sequence, Biological Transport, Cell Line, Conserved Sequence, DNA Primers, DNA-Binding Proteins chemistry, Humans, Models, Molecular, Molecular Sequence Data, Phosphorylation, Protein Conformation, Recombinant Fusion Proteins metabolism, STAT1 Transcription Factor, Sequence Homology, Amino Acid, Trans-Activators chemistry, Cell Nucleus metabolism, Cytoplasm metabolism, DNA-Binding Proteins metabolism, Leucine metabolism, Signal Transduction, Trans-Activators metabolism
- Abstract
Signal transducer and activator of transcription (Stat) proteins are latent transcription factors that reside in the cytoplasm before activation. On cytokine-induced tyrosine phosphorylation, these molecules dimerize and accumulate transiently in the nucleus. No specific signals mediating these processes have been identified to date. In this report, we examine the nuclear export of Stat1. We find that treatment of cells with the export inhibitor leptomycin B does not affect steady-state localization of Stat1 but impedes nuclear export after IFNgamma-induced nuclear accumulation. We identify a conserved leucine-rich helical segment in the coiled-coil domain of Stat1, which is responsible for the efficient nuclear export of this protein. Mutation of two hallmark leucines within this segment greatly attenuate the back transport of Stat1 in the cytoplasm. When fused to a carrier protein, the Stat1 export sequence can mediate nuclear export after intranuclear microinjection. We show that prolonging the nuclear presence of Stat1 by inhibiting nuclear export reduces the transcriptional response to stimulation with IFNgamma. These data suggest that Stats are actively exported from the nucleus via several separate pathways and link this activity to transcriptional activation.
- Published
- 2000
- Full Text
- View/download PDF
45. The significance of tetramerization in promoter recruitment by Stat5.
- Author
-
John S, Vinkemeier U, Soldaini E, Darnell JE Jr, and Leonard WJ
- Subjects
- Base Sequence, Binding Sites, Cell Line, Transformed, DNA metabolism, DNA-Binding Proteins genetics, Dimerization, Humans, Molecular Sequence Data, Mutagenesis, Response Elements, STAT5 Transcription Factor, Trans-Activators genetics, Transcriptional Activation, Tumor Suppressor Proteins, DNA-Binding Proteins metabolism, Milk Proteins, Promoter Regions, Genetic, Receptors, Interleukin-2 genetics, Trans-Activators metabolism
- Abstract
Stat5a and Stat5b are rapidly activated by a wide range of cytokines and growth factors, including interleukin-2 (IL-2). We have previously shown that these signal transducers and activators of transcription (STAT proteins) are key regulatory proteins that bind to two tandem gamma interferon-activated site (GAS) motifs within an IL-2 response element (positive regulatory region III [PRRIII]) in the human IL-2Ralpha promoter. In this study, we demonstrate cooperative binding of Stat5 to PRRIII and explore the molecular basis underlying this cooperativity. We demonstrate that formation of a tetrameric Stat5 complex is essential for the IL-2-inducible activation of PRRIII. Stable tetramer formation of Stat5 is mediated through protein-protein interactions involving a tryptophan residue conserved in all STATs and a lysine residue in the Stat5 N-terminal domain (N domain). The functional importance of tetramer formation is shown by the decreased levels of transcriptional activation associated with mutations in these residues. Moreover, the requirement for STAT protein-protein interactions for gene activation from a promoter with tandemly linked GAS motifs can be relieved by strengthening the avidity of protein-DNA interactions for the individual binding sites. Taken together, these studies demonstrate that a dimeric but tetramerization-deficient Stat5 protein can activate only a subset of target sites. For functional activity on a wider range of potential recognition sites, N-domain-mediated oligomerization is essential.
- Published
- 1999
- Full Text
- View/download PDF
46. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA.
- Author
-
Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr, and Kuriyan J
- Subjects
- Amino Acid Sequence, Crystallography, DNA-Binding Proteins genetics, Dimerization, Humans, Models, Molecular, Molecular Conformation, Molecular Sequence Data, NF-kappa B chemistry, Peptide Fragments chemistry, Peptide Fragments genetics, Phosphorylation, Phosphotyrosine chemistry, Protein Binding, Protein Structure, Tertiary, Recombinant Proteins chemistry, STAT1 Transcription Factor, Sequence Homology, Amino Acid, Synchrotrons, Trans-Activators genetics, Tumor Suppressor Protein p53 chemistry, src Homology Domains, DNA chemistry, DNA-Binding Proteins chemistry, Oligodeoxyribonucleotides chemistry, Trans-Activators chemistry
- Abstract
The crystal structure of the DNA complex of a STAT-1 homodimer has been determined at 2.9 A resolution. STAT-1 utilizes a DNA-binding domain with an immunoglobulin fold, similar to that of NFkappaB and the p53 tumor suppressor protein. The STAT-1 dimer forms a contiguous C-shaped clamp around DNA that is stabilized by reciprocal and highly specific interactions between the SH2 domain of one monomer and the C-terminal segment, phosphorylated on tyrosine, of the other. The phosphotyrosine-binding site of the SH2 domain in each monomer is coupled structurally to the DNA-binding domain, suggesting a potential role for the SH2-phosphotyrosine interaction in the stabilization of DNA interacting elements.
- Published
- 1998
- Full Text
- View/download PDF
47. Structure of the amino-terminal protein interaction domain of STAT-4.
- Author
-
Vinkemeier U, Moarefi I, Darnell JE Jr, and Kuriyan J
- Subjects
- Amino Acid Sequence, Binding Sites, Cell Line, Crystallography, X-Ray, DNA metabolism, DNA-Binding Proteins genetics, DNA-Binding Proteins metabolism, Humans, Hydrogen Bonding, Interferon-gamma pharmacology, Models, Molecular, Molecular Sequence Data, Oligodeoxyribonucleotides metabolism, Protein Structure, Tertiary, STAT1 Transcription Factor, STAT4 Transcription Factor, Signal Transduction, Trans-Activators genetics, Trans-Activators metabolism, Transcription, Genetic, Transfection, src Homology Domains, DNA-Binding Proteins chemistry, Protein Conformation, Trans-Activators chemistry
- Abstract
STATs (signal transducers and activators of transcription) are a family of transcription factors that are specifically activated to regulate gene transcription when cells encounter cytokines and growth factors. The crystal structure of an NH2-terminal conserved domain (N-domain) comprising the first 123 residues of STAT-4 was determined at 1.45 angstroms. The domain consists of eight helices that are assembled into a hook-like structure. The N-domain has been implicated in several protein-protein interactions affecting transcription, and it enables dimerized STAT molecules to polymerize and to bind DNA cooperatively. The structure shows that N-domains can interact through an extensive interface formed by polar interactions across one face of the hook. Mutagenesis of an invariant tryptophan residue at the heart of this interface abolished cooperative DNA binding by the full-length protein in vitro and reduced the transcriptional response after cytokine stimulation in vivo.
- Published
- 1998
- Full Text
- View/download PDF
48. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling.
- Author
-
Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, and Darnell JE Jr
- Subjects
- Adenovirus E1A Proteins metabolism, Animals, CREB-Binding Protein, Cell Line, Glutathione Transferase biosynthesis, Humans, Osteosarcoma, Phosphorylation, Recombinant Fusion Proteins metabolism, STAT1 Transcription Factor, Transcriptional Activation, Transfection, DNA-Binding Proteins metabolism, Interferon-gamma pharmacology, Nuclear Proteins metabolism, Signal Transduction, Trans-Activators metabolism, Transcription Factors metabolism, Transcription, Genetic drug effects
- Abstract
Interferon gamma (IFN-gamma) induces rapid tyrosine phosphorylation of the latent cytoplasmic transcription factor, Stat1, which then forms homodimers, translocates to the nucleus and participates in IFN-gamma-induced transcription. However, little is known of the interactions between Stat1 and the general transcription machinery during transcriptional activation. We show here that Stat1 can directly interact with the CREB-binding protein (CBP)/p300 family of transcriptional coactivators. Specifically, two interaction regions were identified: the amino-terminal region of Stat1 interacts with the CREB-binding domain of CBP/p300 and the carboxyl-terminal region of Stat1 interacts with the domain of CBP/p300 that binds adenovirus E1A protein. Transfection experiments suggest a role for these interactions in IFN-gamma-induced transcription. Because CBP/p300-binding is required for the adenovirus E1A protein to regulate transcription of many genes during viral replication and cellular transformation, it is possible that the anti-viral effect of IFN-gamma is based at least in part on direct competition by nuclear Stat1 with E1A for CBP/p300 binding.
- Published
- 1996
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.